Clorox director Russell J. Weiner acquired 417 deferred stock units on September 30, 2026, in lieu of quarterly director’s fees, and 227 deferred stock units on August 28, 2026, through dividend reinvestment under the Independent Directors’ Deferred Compensation Plan. The units will be settled 100% in Clorox stock in connection with his retirement or other termination of service as a director.
Clorox director Matthew J. Shattock acquired 648.0681 Deferred Stock Units on September 30, 2026, in lieu of quarterly director's fees, and 255.3782 units on August 28, 2026, through dividend reinvestment during the fiscal year under the Independent Directors' Deferred Compensation Plan.
Clorox director Stephanie Plaines acquired 339.4642 Deferred Stock Units on September 30, 2026, in lieu of quarterly director's fees. On August 28, 2026, she acquired 98.9603 Deferred Stock Units through dividend reinvestment during the fiscal year under the Independent Directors' Deferred Compensation Plan. The units will be settled 100% in Clorox stock in connection with her retirement or other termination of service as a director.
Clorox director Pierre R. Breber acquired 416.6152 deferred stock units on September 30, 2026, in lieu of quarterly director’s fees, and 42.6144 units on August 28, 2026, through dividend reinvestment during the fiscal year under the Independent Directors’ Deferred Compensation Plan. The units will be settled 100% in Clorox stock upon Breber’s retirement or other termination of service as a director. Breber also reported 18,000 common shares held indirectly through a family trust as of September 30, 2026.
CLOROX CO (symbol: CLX) is the issuer of record for a Form 4 filing submitted to the SEC. Peck Laurene E reported acquisition or exercise transactions in this Form 4 filing.
CLOROX CO (CLX) reports that Laurene E. Peck, VP - CAO & Corp Controller, received an award of 2,192 restricted stock units on September 23, 2026. The reported per-share price was $83.9400. The units vest in 4 equal installments on October 5, 2027, October 5, 2028, October 5, 2029, and October 5, 2030.
After the award, Peck held 9,160 shares of common stock directly. The report also lists 100 shares held indirectly through the Trust of Parent.
Clorox (CLX) EVP - Chief Admin Officer Marriner Kirsten acquired an award of 12,389 restricted stock units on September 23, 2026. The transaction price was reported as $83.94 per share. The units vest in four equal installments, one-quarter on October 5, 2027, October 5, 2028, October 5, 2029, and October 5, 2030. Kirsten's reported direct holdings after the award were 76,683 shares. No Rule 10b5-1 plan is reported.
CLOROX CO (symbol: CLX) is the issuer of record for a Form 4 filing submitted to the SEC. Hyder Chris T reported acquisition or exercise transactions in this Form 4 filing.
Clorox EVP-Chief Operating Officer Chris T. Hyder was granted 13,342 shares of common stock on September 23, 2026; the transaction lists $83.94 per share. His direct holdings following the award were 90,202 shares. The related restricted stock units vest in four equal installments, one-quarter each on October 5, 2027, October 5, 2028, October 5, 2029, and October 5, 2030.
Clorox EVP and Chief Financial Officer Luc Bellet acquired 11,913 restricted stock units as an award on September 23, 2026; his reported directly held position after the transaction was 74,669 shares. The units vest in four equal installments, one-quarter each on October 5, 2027, 2028, 2029, and 2030. No Rule 10b5-1 plan is reported.
CLOROX CO (CLX) Chief Executive Officer Linda J. Rendle acquired 50,988 restricted stock units on September 23, 2026, in a grant/award transaction; the reported price per share was $83.94. Her directly held Common Stock position following the transaction was 252,149 shares. The units vest in four equal installments, one-quarter on each of October 5, 2027, 2028, 2029, and 2030. No Rule 10b5-1 plan is reported.
Clorox EVP Nina Barton acquired an award of 10,721 restricted stock units on September 23, 2026. Reported direct holdings following the transaction were 37,164 shares. The units vest in four equal installments on October 5, 2027, 2028, 2029, and 2030. No Rule 10b5-1 plan is reported.